Ergoteles’s Enviva Inc. EVA Stock Holding History

Ergoteles’s Portfolio EVA Stock Details EVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-13,931	Closed	-$797K	–	2093
2022 Q2	$797K	Buy	+13,931	New	+$1.05M	0.02%	646

Other funds holding EVA

Riverstone Holdings New York $36.9M AUM 80.85% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

KACA

Kayne Anderson Capital Advisors Los Angeles, California $5.22B AUM 17.11% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

GKIM

GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Ergoteles's EVA Position: Q3 2022 in Review

Ergoteles sold out of Enviva Inc. (EVA) in Q3 2022, closing a stake of 13,931 shares — an estimated $797K sold.

Ergoteles first reported a position in EVA in Q2 2022 and held it in 1 quarter. The position peaked at $797K in Q2 2022. 178 funds tracked by Wall St. Rank hold EVA as of Q3 2022.

Ergoteles reported no remaining Enviva Inc. position as of Q3 2022 after selling out during the quarter.
Ergoteles sold 13,931 Enviva Inc. shares in Q3 2022, an estimated $797K.
Ergoteles first reported a position in Enviva Inc. in Q2 2022 and held it in 1 quarter.
Ergoteles's Enviva Inc. position peaked at $797K in Q2 2022.
178 funds tracked by Wall St. Rank held Enviva Inc. as of Q3 2022.

Based on Ergoteles's 13F filing for Q3 2022, filed 14 Nov 2022.